The latest news & stories from the Providence Research Network

More than 20 presentations across 12 conferences highlight work in tumor immunology, molecular diagnostics, computational pathology and patient navigation.

Julie Kamps’ ovarian cancer journey began with a conversation between sisters. Today, her story is a reminder to speak up, seek answers, and pay attention to changes in your health.

Researchers evaluate whether adding pumitamig to chemotherapy can extend the lives of people with TNBC.

Good clinician-patient relationships and stable living situations are key for atrial fibrillation patients to take their medications as prescribed, according to a recent Providence study

Dr. Katherine Tuttle's work has helped advance care for people with kidney, heart and metabolic diseases.

A study from Providence CORE and Health Share of Oregon links housing instability and serious mental illness to increased health care use among adult Medicaid members in the Portland Metropolitan regi

Providence Cancer Institute is enrolling patients in a clinical trial to test Mo-Rez.

Many people with advanced NSCLC still need better treatment options. This study is evaluating an investigational medication that may help them live longer.

The Montana Child Abuse Network is a pilot project funded by RESOLVE: A Rural Health Collaborative, a strategic partnership between Providence and the University of Montana.

Their extraordinary commitment will create Oregon’s first-ever women’s health hospital and launch the next generation of pioneering heart care.

A Providence-led research collaboration with the Centers for Disease Control and Prevention is drawing national attention for its impact on improving care for older adults.

Research is at the core of advancing medical care. It helps us better understand how diseases progress, how treatments work, and how to improve care.

For more than a decade, Providence and UCLA researchers have partnered on an ambitious effort to create a comprehensive, real-world picture of chronic kidney disease: the CURE-CKD Registry.

Research from CORE and Providence Genomics found that in a large genetic screening program, few patients discussed genetic screening results with a healthcare provider.

Del survived Arctic winters, a demanding career and cancer – twice. Here’s how a pioneering Providence Cancer Institute trial helped him beat it a second time.

Providence Cancer Institute is enrolling patients with hepatocellular carcinoma in a trial of pumitamig, an investigational bispecific antibody.

Grant‑funded collaboration focuses on mRNA vaccine technology to strengthen personalized T‑cell therapies for pancreatic cancer

New research from Providence suggests that a specialized training for frontline clinicians could help address drivers of healthcare workforce burnout.

Prestigious grants will help researchers pursue important cancer studies.